Filtros de búsqueda

Lista de obras de

Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes

artículo científico publicado en 2008

Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA.

artículo científico publicado en 2016

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

artículo científico publicado en 2014

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study

scientific article published on 01 April 2010

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

artículo científico publicado en 2014

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

artículo científico publicado en 2017

Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years.

artículo científico

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register

artículo científico publicado en 2013

Incidence of cancer in patients with spondyloarthritis treated with anti-tnf drugs

artículo científico publicado en 2017

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

artículo científico publicado en 2012

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

artículo científico publicado en 2013

Predicting response to anti-TNF treatment in rheumatoid arthritis patients

artículo científico publicado en 2009

Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores

artículo científico publicado en 2013

Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome

artículo científico publicado en 2005

Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study

artículo científico publicado en 2015

Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study

artículo científico publicado en 2014

Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients.

artículo científico publicado en 2008

Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry

scientific article published on 31 December 2009

Switching rheumatoid arthritis treatments: an update.

scientific article published on 22 January 2011

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice

scientific article published on 01 September 2009

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal

artículo científico publicado en 2008

Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry

scientific article published on 30 July 2009

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda